Oxiperomide in tardive dyskinesia

Daniel Casey, J. Gerlach

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Tardive dyskinesia can be suppressed by dopaminergic receptor blockers, but often at the cost of reciprocal increase in Parkinsonism. Oxiperomide, a dopaminergic antagonist that has been shown to reduce levodopa-induced dyskinesias without producing an equal aggravation of Parkinsonism, was evaluated in a blind placebo-controlled trial in 10 patients with tardive dyskinesia. It decreased tardive dyskinesia significantly (p

Original languageEnglish (US)
Pages (from-to)264-267
Number of pages4
JournalJournal of Neurology Neurosurgery and Psychiatry
Volume43
Issue number3
StatePublished - 1980
Externally publishedYes

Fingerprint

Parkinsonian Disorders
Dopamine Antagonists
Dyskinesias
Levodopa
Placebos
Tardive Dyskinesia
oxiperomide

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this

Oxiperomide in tardive dyskinesia. / Casey, Daniel; Gerlach, J.

In: Journal of Neurology Neurosurgery and Psychiatry, Vol. 43, No. 3, 1980, p. 264-267.

Research output: Contribution to journalArticle

Casey, D & Gerlach, J 1980, 'Oxiperomide in tardive dyskinesia', Journal of Neurology Neurosurgery and Psychiatry, vol. 43, no. 3, pp. 264-267.
Casey, Daniel ; Gerlach, J. / Oxiperomide in tardive dyskinesia. In: Journal of Neurology Neurosurgery and Psychiatry. 1980 ; Vol. 43, No. 3. pp. 264-267.
@article{b92f624a0f5c48c9adc4715e7d8448ca,
title = "Oxiperomide in tardive dyskinesia",
abstract = "Tardive dyskinesia can be suppressed by dopaminergic receptor blockers, but often at the cost of reciprocal increase in Parkinsonism. Oxiperomide, a dopaminergic antagonist that has been shown to reduce levodopa-induced dyskinesias without producing an equal aggravation of Parkinsonism, was evaluated in a blind placebo-controlled trial in 10 patients with tardive dyskinesia. It decreased tardive dyskinesia significantly (p",
author = "Daniel Casey and J. Gerlach",
year = "1980",
language = "English (US)",
volume = "43",
pages = "264--267",
journal = "Journal of Neurology, Neurosurgery and Psychiatry",
issn = "0022-3050",
publisher = "BMJ Publishing Group",
number = "3",

}

TY - JOUR

T1 - Oxiperomide in tardive dyskinesia

AU - Casey, Daniel

AU - Gerlach, J.

PY - 1980

Y1 - 1980

N2 - Tardive dyskinesia can be suppressed by dopaminergic receptor blockers, but often at the cost of reciprocal increase in Parkinsonism. Oxiperomide, a dopaminergic antagonist that has been shown to reduce levodopa-induced dyskinesias without producing an equal aggravation of Parkinsonism, was evaluated in a blind placebo-controlled trial in 10 patients with tardive dyskinesia. It decreased tardive dyskinesia significantly (p

AB - Tardive dyskinesia can be suppressed by dopaminergic receptor blockers, but often at the cost of reciprocal increase in Parkinsonism. Oxiperomide, a dopaminergic antagonist that has been shown to reduce levodopa-induced dyskinesias without producing an equal aggravation of Parkinsonism, was evaluated in a blind placebo-controlled trial in 10 patients with tardive dyskinesia. It decreased tardive dyskinesia significantly (p

UR - http://www.scopus.com/inward/record.url?scp=0018841170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018841170&partnerID=8YFLogxK

M3 - Article

C2 - 7373324

AN - SCOPUS:0018841170

VL - 43

SP - 264

EP - 267

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

IS - 3

ER -